- Category
- Small (2024-25)
- Udyam number
- UDYAM-BR-26-0012872

About Salas Pharmaceuticals Private Limited
Data last updated:
Salas Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 November 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24230BR2009PTC014997. Its GSTIN is 10AANCS5537N1ZZ (Bihar). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹2.05 Cr and a paid-up capital of ₹2.05 Cr. It is led by directors including Suman Kumar Chaudhary and Vindhya Prakash.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Opposite – Cda Building Rajendra Path Kadamkuan, Patna, Bihar, India – 800001.
As per the financials filed for FY 2024, the company reported a revenue of ₹35.84 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹2.23 Cr (net margin 6.2%) and EBITDA of ₹4.08 Cr (EBITDA margin 11.4%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 21% over five years.
The company has about 227 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Salas Pharmaceuticals. As per MCA filings, the company has open charges of ₹9.35 Cr and satisfied charges of ₹1.6 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it.
Salas Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0012872). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website salaspharma.co.in.
Company details
Recognitions & Rankings of Salas Pharmaceuticals
Contact details
Salas Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its website is salaspharma.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOpposite – Cda Building Rajendra Path Kadamkuan, Patna, Bihar, India – 800001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Salas Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Salas Pharmaceuticals operates one associated brand: Salas Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A healthcare company specializing in multidisciplinary engineering and technical services. | salaspharma.co.in |
Business activity
The main business activity of Salas Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Salas Pharmaceuticals Private Limited, buy the company report.
Financials of Salas Pharmaceuticals Private Limited
FY 2025 filings availableSalas Pharmaceuticals Private Limited reported revenue of ₹35.84 Cr (up 13% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 13% growth in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.08 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.23 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.4% | ||||
| Net Profit Margin | 6.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Salas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Salas Pharmaceuticals Private Limited
Salas Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suman Kumar Chaudhary | Director | 13 Nov 2009 | 17 Years 0 Months | Current |
| Vindhya Prakash | Director | 13 Nov 2009 | 17 Years 0 Months | Current |
| Prem Sagar | Director | 13 Nov 2009 | 17 Years 0 Months | Current |
| Viresh Kumar Verma | Director | 23 Feb 2010 | 16 Years 8 Months | Current |
Peer comparison
Salas Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Prim Drugs & Pharmaceuticals (India) Private Limited | ₹35.97 Cr (FY 2024) | 62.0% | Sriperumbudur, Tamil Nadu, India | |||
| Challa Chlorides Pvt Ltd | ₹35.87 Cr (FY 2024) | 58.0% | Panjagutta, Hyderabad, Telangana, India | |||
| Salas Pharmaceuticals Private Limitedthis company | ₹35.84 Cr (FY 2024) | ₹2.23 Cr | 6.2% | 13.0% | 227 | Patna, Bihar, India |
| Meridian Medicare Limited | ₹35.84 Cr (FY 2025) | 4.0% | Himachal Pradesh, India | |||
| Radicura Pharmaceuticals Private Limited | ₹35.79 Cr (FY 2025) | -5.0% | New Delhi, Delhi, India | |||
| Vetindia Pharmaceuticals Limited | ₹35.78 Cr (FY 2024) | -10.0% | Telangana, India |
To see the full peer comparison of Salas Pharmaceuticals Private Limited, buy the company report.
Auditor
Salas Pharmaceuticals Private Limited is audited by MASHI MAHESHWARI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MASHI MAHESHWARI & CO | FY 2023 | 21996N |
Shareholding
The shareholding of Salas Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Salas Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Aug 2016 | 100055516 | Others | ₹9.35 Cr | Open | |
| 01 Jun 2022 | 100580587 | Others | ₹15 Lakh | Satisfied | |
| 31 Dec 2020 | 100405819 | Indian Bank | ₹10.9 Lakh | Satisfied | |
| 18 Dec 2020 | 100405798 | Indian Bank | ₹1.22 Cr | Satisfied | |
| 02 Mar 2019 | 100245330 | Others | ₹12.28 Lakh | Satisfied |
To see the full charge records of Salas Pharmaceuticals Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Salas Pharmaceuticals Private Limited has 2 court cases on record: 1 filed by Salas Pharmaceuticals, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ranchi, Jharkhand | Criminal complaint | Filed against the company by State of Jharkhand | Disposed |
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against an individual | Disposed |
To see the full case history of Salas Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Salas Pharmaceuticals Private Limited was last rated by Care on 28 Oct 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 28 Oct 2021 |
To see the full credit ratings and regulatory alerts of Salas Pharmaceuticals Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Salas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Salas Pharmaceuticals Private Limited has a workforce of 227 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 227 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Salas Pharmaceuticals Private Limited, buy the company report.
GST
Salas Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AANCS5537N1ZZ | Bihar | Active | 01 Jul 2017 |
| 11AANCS5537N1ZX | Sikkim | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Salas Pharmaceuticals Private Limited, buy the company report.
Recent activity
Salas Pharmaceuticals Private Limited has 4 board changes on record since 2009: 4 appointments. The latest: Viresh Kumar Verma was appointed as Director on 23 Feb 2010.
5 earlier events are in the company report.
Frequently asked questions
Salas Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 November 2009 (17+ years old) and is registered under CIN U24230BR2009PTC014997.
Salas Pharmaceuticals has 4 current directors:
- Suman Kumar Chaudhary - Director
- Vindhya Prakash - Director
- Prem Sagar - Director
- Viresh Kumar Verma - Director
The latest financial statements of Salas Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Salas Pharmaceuticals is 10AANCS5537N1ZZ, registered in Bihar. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 11AANCS5537N1ZX (Sikkim).
The CIN (Corporate Identification Number) of Salas Pharmaceuticals is U24230BR2009PTC014997. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Salas Pharmaceuticals has 2 court cases on record: 1 filed by the company and 1 filed against it.
Salas Pharmaceuticals was incorporated on 13 November 2009, making it 17+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Salas Pharmaceuticals by revenue are Prim Drugs & Pharmaceuticals (India) Private Limited, Challa Chlorides Pvt Ltd, Meridian Medicare Limited, Radicura Pharmaceuticals Private Limited, Vetindia Pharmaceuticals Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Viresh Kumar Verma was appointed as Director on 23 Feb 2010. Prem Sagar was appointed as Director on 13 Nov 2009. Suman Kumar Chaudhary was appointed as Director on 13 Nov 2009. Salas Pharmaceuticals has 4 board changes on record in total.
Yes, Salas Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-BR-26-0012872).
Salas Pharmaceuticals can be reached through the website salaspharma.co.in. Its registered office is in Patna, Bihar, India.

